Skip to main content

Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.

Publication ,  Journal Article
Chiong, W; Tolchin, BD; Bonnie, RJ; Busl, K; Cruz-Flores, S; Epstein, LG; Greene, EP; Illes, J; Kirschen, M; Larriviere, DG; Mantri, S ...
Published in: Neurology
January 25, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

January 25, 2022

Volume

98

Issue

4

Start / End Page

154 / 159

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chiong, W., Tolchin, B. D., Bonnie, R. J., Busl, K., Cruz-Flores, S., Epstein, L. G., … Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS), . (2022). Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology, 98(4), 154–159. https://doi.org/10.1212/WNL.0000000000013053
Chiong, Winston, Benjamin David Tolchin, Richard J. Bonnie, Katharina Busl, Salvador Cruz-Flores, Leon G. Epstein, Ericka P. Greene, et al. “Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.Neurology 98, no. 4 (January 25, 2022): 154–59. https://doi.org/10.1212/WNL.0000000000013053.
Chiong W, Tolchin BD, Bonnie RJ, Busl K, Cruz-Flores S, Epstein LG, et al. Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology. 2022 Jan 25;98(4):154–9.
Chiong, Winston, et al. “Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.Neurology, vol. 98, no. 4, Jan. 2022, pp. 154–59. Pubmed, doi:10.1212/WNL.0000000000013053.
Chiong W, Tolchin BD, Bonnie RJ, Busl K, Cruz-Flores S, Epstein LG, Greene EP, Illes J, Kirschen M, Larriviere DG, Mantri S, Rubin MA, Stern BJ, Taylor LP, Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS). Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology. 2022 Jan 25;98(4):154–159.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

January 25, 2022

Volume

98

Issue

4

Start / End Page

154 / 159

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences